Celinda M. Kofron

EngineeringNeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues”.

A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues

Scientific Reports(2021)10.1038/s41598-021-89478-9

N/A

0DataRank · unranked

41 citations

Tae Yun Kim, Fabiola Munarin, Arvin H. Soepriatna, Rajeev J. Kant, Ulrike Mende +3 more

A Predictive in Vitro Risk Assessment Platform for Pro-Arrhythmic Toxicity Using Human 3D Cardiac Microtissues

Research Square(2021)10.21203/rs.3.rs-147721/v1

N/A

0DataRank · unranked

2 citations

Tae Yun Kim, Fabiola Munarin, Arvin H. Soepriatna, Rajeev J. Kant, Ulrike Mende +3 more

Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues

PLoS ONE(2023)10.1371/journal.pone.0280406

N/A

0DataRank · unranked

10 citations

Allison Navarrete-Welton, Tae Yun Kim, Mark C. Daley, Peter Bronk, Celinda M. Kofron +4 more

In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment

Toxicological Sciences(2024)10.1093/toxsci/kfae079

N/A

0DataRank · unranked

7 citations

Marjory Moreau, Peter Bronk, Jeffrey W. Fisher, Celinda M. Kofron, Ulrike Mende +4 more